Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations

Laura M Pollard1, Julie R Jones, Tim C Wood

  • 1Biochemical Diagnostic Laboratory, Greenwood Genetic Center, 106 Gregor Mendel Circle, Greenwood, SC 29646, USA. lpollard@ggc.org

Insights

This study identified 104 new mutations across six mucopolysaccharidosis (MPS) types in 355 patients, revealing gene-specific mutation patterns and heterogeneity. Findings aid in diagnosing and counseling MPS patients.

Area of Science:

  • Biochemistry
  • Genetics
  • Rare Diseases

Background:

  • Mucopolysaccharidosis (MPS) disorders are a group of rare genetic diseases.
  • They result from deficiencies in lysosomal enzymes crucial for glycosaminoglycan degradation.
  • This leads to the accumulation of these substances, causing various clinical phenotypes.

Purpose of the Study:

  • To perform molecular analysis on a cohort of 355 MPS patients across six subtypes (MPSI, MPSII, MPSIIIA, MPSIIIB, MPSIVA, MPSVI).
  • To identify and characterize novel mutations in the involved genes.
  • To compare mutation heterogeneity, mutation types, and distribution across different MPS genes.

Main Methods:

  • Conducted molecular analysis on 355 MPS patients.
  • Identified mutations in IDUA, IDS, SGSH, NAGLU, GALNS, and ARSB genes.
  • Analyzed mutation heterogeneity, mutation types (missense, nonsense), and exonic distribution.
  • Determined de novo mutation rate in MPSII through maternal testing.

Main Results:

  • Discovered 104 previously unreported mutations across the studied MPS genes.
  • Observed significant differences in mutation heterogeneity and types between genes.
  • IDUA gene showed a high proportion of nonsense mutations (56%), while SGSH, GALNS, and ARSB predominantly had missense mutations.
  • Identified potential mutation 'hot-spots' in IDS, SGSH, and NAGLU genes.
  • Found that 22.5% of IDS mutations in MPSII patients were de novo.

Conclusions:

  • The molecular characterization provides valuable insights into the genetic basis of various MPS disorders.
  • Understanding gene-specific mutation patterns aids in accurate diagnosis and genetic counseling for MPS.
  • The identification of de novo mutations and mutation hotspots contributes to a deeper understanding of MPS etiology.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Mutations01:39

Mutations

Overview
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Mutations in Microorganisms01:18

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...